NFKB1 and glioblastoma: PN synergistically increased the anticancer effect of cisplatin in both apoptotic and sub-apoptotic concentrations in GBM rat and human cell lines, overcoming cisplatin resistance in GBM rat cells, probably through NF-κB inhibition [115].